Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
The tissue heart valves market has been steadily advancing, driven by growing cardiovascular health challenges and innovations in valve technology. As medical procedures evolve and patient needs increase, this sector is set to experience continued growth and development. Below is a detailed examination of the market size, key drivers, segments, trends, major players, and regional outlook.
Current and Future Market Size of the Tissue Heart Valves Market
The tissue heart valves market has demonstrated consistent growth, with its size projected to rise from $1.52 billion in 2025 to $1.56 billion in 2026, representing a compound annual growth rate (CAGR) of 2.6%. This upward trend in the past years has largely been supported by the rising incidence of cardiovascular diseases, the limitations tied to mechanical valves, increased adoption of surgical valve replacements, improvements in hospital cardiac infrastructure, and an aging population. Moving ahead, the market is anticipated to continue expanding, reaching $1.72 billion by 2030 at a CAGR of 2.5%. Key factors behind this forecast include the increased use of transcatheter aortic valve replacement (TAVR) procedures, growth in minimally invasive cardiac surgeries, innovations aimed at extending valve durability, improved access to healthcare, and a rise in cardiology specialization. Prominent trends projected to influence the market include a preference for bioprosthetic valves, more transcatheter valve interventions, advances in tissue preservation, decreased reliance on long-term anticoagulation therapies, and higher demand driven by aging populations needing valve replacements.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21302&type=smp
Primary Factors Fueling Growth in the Tissue Heart Valves Market
The growing burden of cardiovascular diseases is a major driver propelling the tissue heart valves market forward. Cardiovascular diseases encompass a range of conditions affecting the heart and blood vessels, including heart attacks, strokes, hypertension, and related disorders. This rise is attributed to several factors such as unhealthy lifestyle choices, aging demographics, increased presence of risk factors, poor nutritional habits, physical inactivity, smoking, stress, and urban living, all contributing to greater rates of heart-related illnesses worldwide.
Tissue heart valves play a critical role in treating cardiovascular diseases by offering biocompatible, durable, and less thrombogenic solutions for patients requiring valve replacement. These valves help improve heart function over time while minimizing complications. For example, a September 2024 report by the Heart Failure Society of America highlighted that nearly 6.7 million Americans aged 20 and above currently live with heart failure, with projections estimating this will rise to 8.7 million by 2030, 10.3 million by 2040, and 11.4 million by 2050. This growing patient base directly supports the expanding demand for tissue heart valves.
Detailed Segmentation and Growth Opportunities in the Tissue Heart Valves Market
The tissue heart valves market is categorized into distinct segments to provide a clearer picture of opportunities and growth patterns. These include:
1) By Type: Stented Tissue Heart Valves and Stentless Tissue Heart Valves
2) By Procedure Type: Surgical Aortic Valve Replacement (SAVR) and Transcatheter Aortic Valve Replacement (TAVR)
3) By End-User: Hospitals, Ambulatory Surgical Centers, and Other End-Users
Further classifications break down stented tissue heart valves into bovine pericardial valves and porcine valves, while stentless tissue heart valves include bovine pericardial stentless valves and homograft valves. This segmentation allows for targeted insights into product demand and technological advancements across various patient groups and treatment methods.
Access The Complete Tissue Heart Valves Market Report:
https://www.thebusinessresearchcompany.com/report/tissue-heart-valves-global-market-report
Emerging Innovations Shaping the Tissue Heart Valves Industry
Industry leaders in the tissue heart valves market are prioritizing the development of advanced products that simplify implantation and enhance long-term patient outcomes. Among these is the surgical aortic tissue valve, a biologically derived prosthetic valve used to replace damaged aortic valves during surgery.
For instance, in June 2024, Medtronic plc., an Ireland-headquartered technology company, introduced the Avalus Ultra valve. This next-generation surgical aortic tissue valve is designed to improve ease of use during implantation and support ongoing patient care. Building on a decade of clinical experience with the Avalus valve, the Avalus Ultra features a low-profile design, a polyetheretherketone (PEEK) base frame ensuring consistent circularity, and an industry-leading Effective Orifice Area (EOA) that promotes better blood flow. It also incorporates a radiopaque coil for enhanced visibility during future valve-in-valve procedures, providing durable treatment options for patients with aortic stenosis.
Key Players Leading the Tissue Heart Valves Market
Several prominent companies dominate the tissue heart valves market, including Abbott Laboratories, Medtronic PLC, Edwards Lifesciences Corporation, LivaNova PLC, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, LifeNet Health Inc., TTK Healthcare Ltd., Braile Biomédica, Anteris Technologies Ltd., Labcor Laboratórios Ltd., CARDION s.r.o., CryoLife Inc., Colibri Heart Valve LLC, Foldax Inc., Balance Medical Technologies Co. Ltd., MiCardia Corporation, St. Jude Medical Inc., Sorin Group, and Hancock J & Co. Their ongoing innovations and market strategies play a crucial role in shaping industry dynamics and expanding access to advanced heart valve therapies.
Regional Market Insights and Growth Dynamics
In 2025, North America stood as the largest regional market for tissue heart valves. However, looking ahead, the Asia-Pacific region is expected to experience the fastest growth during the forecast period. The overall market analysis covers several key regions, including Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, providing a comprehensive perspective on global developments and regional opportunities.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
